Feticide Laws in India: A Critical Look at Prevention and Enforcement

India’s fight against feticide represents a crucial intersection of law, healthcare, and human rights. With a historically skewed sex ratio and deep-rooted gender bias, the country has enacted comprehensive legislation to combat the practice of sex-selective abortion and female feticide. Understanding these laws is essential for recognizing how legal frameworks protect the right to life and promote gender equality.

The legal framework protecting against feticide 🔗

India has established two principal laws to address feticide: the Medical Termination of Pregnancy Act and the Pre-Conception and Pre-Natal Diagnostic Techniques Act. These laws work in tandem to ensure safe abortion access while preventing the misuse of medical technology for sex determination.

The Medical Termination of Pregnancy Act, originally enacted in 1971, provides the legal framework for safe and legal abortion in India. The 2021 amendment significantly expanded access by increasing the gestational limit from 20 to 24 weeks for special categories of women, including survivors of rape, victims of incest, minors, and differently-abled women. This law serves as an exception to the Indian Penal Code, which otherwise criminalizes causing miscarriage.

Key provisions of the MTP Amendment Act 2021 🔗

The amended law introduced several important changes. For pregnancies up to 20 weeks, only one medical practitioner’s opinion is required, while pregnancies between 20-24 weeks require two providers’ opinions. The Act also extends the failure of contraceptive clause to unmarried women, recognizing reproductive autonomy regardless of marital status.

A critical protection under the Act is the confidentiality clause, which mandates that the name and particulars of a woman whose pregnancy has been terminated cannot be revealed except to persons authorized by law. Additionally, for cases involving substantial foetal abnormalities, the upper gestational limit does not apply, and women can approach state Medical Boards for decisions within three days.

The PCPNDT Act: Preventing sex-selective practices 🔗

The Pre-Conception and Pre-Natal Diagnostic Techniques Act, enacted in 1994 and amended in 2003, directly addresses the misuse of medical technology for sex determination. This legislation specifically prohibits prenatal sex determination and bans the use of sex selection techniques both before and after conception.

The Act emerged in response to India’s declining child sex ratio. According to census data, the sex ratio in the 0-6 age group deteriorated from 104.0 males per 100 females in 1981 to 109.4 in 2011, with certain states like Punjab and Haryana showing significantly higher ratios. This trend revealed widespread female feticide driven by patriarchal preferences for male children.

Prohibited activities under the PCPNDT Act 🔗

Offences under this Act include conducting or assisting prenatal diagnostic techniques in unregistered facilities, performing sex selection procedures, conducting tests for purposes other than those specified in the Act, and selling or distributing ultrasound machines capable of detecting fetal sex. The law also prohibits advertising sex determination services in any form, whether through print, electronic media, or physical displays.

The Act mandates compulsory registration of all diagnostic laboratories, genetic counseling centers, and ultrasound clinics with appropriate authorities. Only qualified medical professionals can perform diagnostic procedures, and detailed records of each procedure must be maintained.

Penalties and enforcement mechanisms 🔗

The PCPNDT Act imposes serious consequences for violations. Healthcare professionals found guilty can face imprisonment ranging from three to five years, depending on the severity of the violation. Financial penalties start at Rs. 50,000 for the first offense, with increased penalties for subsequent violations.

All offenses under the Act are cognizable, non-bailable, and non-compoundable, with penalties including imprisonment of up to three to five years and fines ranging from Rs. 10,000 to Rs. 100,000 or more. Medical practitioners can also face suspension or permanent cancellation of their licenses for violations.

Advertising restrictions 🔗

Anyone advertising prenatal or pre-conception sex determination facilities through any medium, including notices, electronic or print media, hoardings, or wall paintings, can be imprisoned for up to three years and fined Rs. 10,000. This comprehensive ban covers traditional and digital platforms, acknowledging the shift of illegal promotion to online spaces.

Roles of stakeholders in enforcement 🔗

The PCPNDT Act establishes a multi-tiered enforcement structure. The Central Supervisory Board, State Supervisory Boards, and district-level Appropriate Authorities oversee implementation and monitoring. These bodies have powers to conduct inspections, order searches and seizures, and suspend or cancel registrations of violating facilities.

The Appropriate Authority, typically a designated medical officer at the district level, has the power to investigate violations and conduct raids. However, under the Act’s framework, only the Appropriate Authority can initiate complaint proceedings, not regular police personnel.

The role of Medical Boards 🔗

The 2021 MTP Amendment Act mandates that each state government constitute Medical Boards comprising a gynecologist, pediatrician, radiologist or sonologist, and other members as notified. These boards evaluate cases involving substantial fetal abnormalities beyond 24 weeks gestation and must provide decisions within three days of being approached.

How to report violations 🔗

Citizens play a vital role in enforcing these laws by reporting suspected violations. Complaints about PCPNDT violations must be filed with the Appropriate Authority designated under the Act rather than through regular police FIRs. This specialized mechanism ensures proper investigation by authorities familiar with medical and legal complexities.

Several states have established dedicated helplines for reporting violations. For instance, Pune Municipal Corporation operates a toll-free helpline at 1800-233-6099 for complaints regarding PCPNDT Act violations. Similar helplines operate in other cities and states across India.

Whistleblower incentives 🔗

Some states have introduced schemes like the “Mukhbir Yojna” which rewards individuals who report doctors or medical personnel engaging in sex determination or female feticide practices with up to Rs. 2 lakh. Such initiatives encourage public participation in enforcement while protecting informants.

Challenges in enforcement and emerging issues 🔗

Despite robust legal frameworks, enforcement faces significant challenges. The Supreme Court has noted that record-keeping violations are not merely technical lapses but represent crucial evidence for identifying accused parties. Low conviction rates, institutional gaps, and the migration of illegal promotion to digital platforms weaken the Act’s effectiveness.

The digital age presents new enforcement challenges. Influencers and unqualified practitioners now use social media platforms to promote unscientific gender-prediction methods, circumventing traditional regulatory mechanisms. This requires updated strategies including tech-enabled monitoring and collaboration with technology platforms to remove sex-selection content.

Balancing medical autonomy and compliance 🔗

Healthcare providers face strict documentation requirements that, while necessary for preventing misuse, can be burdensome. The Supreme Court has upheld that non-maintenance of records is not merely procedural but the most significant evidence for identifying violations. This places a high compliance burden on medical facilities while recognizing that such measures are essential for protecting the girl child’s right to life.

Moving forward: A comprehensive approach 🔗

Effective prevention of feticide requires more than legal enforcement. It demands societal transformation to challenge deep-rooted gender bias and son preference. Government initiatives like Beti Bachao Beti Padhao aim to address declining child sex ratios through awareness campaigns promoting the value of girl children.

The legal framework must be complemented by accessible reproductive healthcare, comprehensive abortion care at all levels, and education about the adverse effects of gender discrimination. Strengthening institutional frameworks with dedicated authorities, leveraging technology for real-time tracking, and ensuring swift justice are crucial next steps.

What do you think? How can India more effectively balance protecting medical autonomy with preventing sex-selective practices? What role should technology platforms play in monitoring and removing illegal content promoting sex determination?

References

1. https://www.who.int/india/news/item/13-04-2021-india-s-amended-law-makes-abortion-safer-and-more-accessible
2. https://prsindia.org/billtrack/the-medical-termination-of-pregnancy-amendment-bill-2020
3. https://www.pib.gov.in/Pressreleaseshare.aspx?PRID=1705381
4. https://en.wikipedia.org/wiki/Pre-Conception_and_Pre-Natal_Diagnostic_Techniques_Act,_1994
5. https://nhmmeghalaya.nic.in/programmes/pcpndt/pcpndt.html
6. https://mednlaw.com/understanding-the-pcpndt-act-a-comprehensive-guide/
7. https://www.drishtiias.com/daily-updates/daily-news-analysis/pc-pndt-act-in-the-digital-age
8. https://byjus.com/free-ias-prep/pre-conception-and-pre-natal-diagnostic-techniques-prohibition-of-sex-selection-act-1994/
9. https://www.drishtijudiciary.com/current-affairs/sex-determination-offence-under-pcpndt-act
10. https://www.verdictum.in/court-updates/high-courts/dr-brij-pal-singh-v-state-of-uttar-pradesh-and-another-2024ahc159207-allahabad-high-court-1554415
11. https://pmc.gov.in/en/pcpndt-section-bogus-doctor-finding-and-action-committee
12. https://blog.ipleaders.in/pre-conception-and-pre-natal-diagnostic-techniques-prohibition-of-sex-determination-act-2003/